Introduction
Diabetic foot ulcers develop in a substantial proportion of people with diabetes over their lifetime and remain among the leading precursors to lower-extremity amputation. Once a wound is present, clinicians rely on debridement, infection control, offloading, glycemic optimization, and adjunctive wound-bed therapies to promote closure. Negative pressure wound therapy (NPWT) — controlled subatmospheric pressure applied to a wound through a sealed dressing system — is one of the more extensively studied adjunctive options, particularly for wounds following surgical debridement or partial foot amputation. Because trial quality and reported outcomes have varied considerably, it is worth examining what the pooled evidence from the past decade actually supports.
How Negative Pressure Wound Therapy Works
NPWT systems apply continuous or intermittent subatmospheric pressure to a wound bed, typically through a foam or gauze interface connected to a suction pump. Proposed mechanisms include removal of exudate and infectious material, reduction of local edema, mechanical stimulation that promotes angiogenesis and granulation tissue formation, and reduced bacterial bioburden. NPWT is used as an adjunct to standard wound care, not a replacement for it — debridement, offloading, vascular assessment, and infection management remain foundational, with NPWT applied to a wound bed that has already been appropriately prepared.
What the Trials and Meta-Analyses Show
Wound Healing and Granulation Tissue Formation
A 2025 systematic review and meta-analysis in the Journal of Clinical Medicine pooled 11 clinical trials comprising 1,117 participants comparing NPWT to conventional dressings in diabetic foot ulcers. NPWT was associated with significantly accelerated granulation tissue formation, greater reductions in wound size, and lower reported pain scores; no statistically significant difference in minor amputation rates was found in this particular pooled analysis. The authors noted substantial heterogeneity across included trials (I² greater than 90%), small sample sizes, and inconsistent blinding — a persistent challenge in wound care research, where blinding patients and assessors to dressing type is often impractical.
Amputation Risk Across Overlapping Meta-Analyses
Because multiple overlapping meta-analyses on this topic exist, a 2025 methodological review in Diabetes, Metabolic Syndrome and Obesity evaluated eight meta-analyses published between 2014 and 2025 to identify the most reliable synthesis of the evidence. Using a formal quality-appraisal algorithm, the reviewers found the highest-quality pooled analysis showed a significantly improved healing rate (risk ratio 1.46) and reduced amputation rate (risk ratio 0.69) with NPWT, along with shortened granulation time and no increase in adverse events. They cautioned that safety reporting across underlying trials was often inconsistent, with possible underreporting of complications such as bleeding or periwound maceration.
Guideline-Level Recommendations
The International Working Group on the Diabetic Foot (IWGDF) addressed NPWT in its 2023 update on interventions to enhance healing of diabetic foot ulcers, published in Diabetes/Metabolism Research and Reviews. The guideline issued a conditional, supportive recommendation for NPWT specifically in postoperative wounds — those resulting from surgical debridement or partial amputation — where standard best practice alone has not achieved healing and where necessary resources are available. Across the 29 recommendations in that guideline, the authors emphasized that overall certainty of the underlying evidence remains low to moderate.
Earlier Evidence Base
An earlier Cochrane review by Liu and colleagues, last updated in 2018, similarly concluded that available evidence was of low certainty and called for adequately powered, well-designed randomized trials. The trajectory from that assessment to the more favorable, though still heterogeneous, findings of the 2025 pooled analyses illustrates how the evidence base for NPWT in diabetic foot wounds has matured over the past decade, even as gaps in trial quality persist.
Clinical Considerations and Limitations
Several practical considerations shape appropriate use of NPWT in diabetic foot wounds. Adequate arterial perfusion should be established before initiating therapy, since NPWT is not a substitute for revascularization in significant peripheral arterial disease. The wound bed requires debridement of necrotic or non-viable tissue before negative pressure is applied. Active untreated infection, exposed vasculature or nerve structures, and malignancy within the wound bed are generally regarded as contraindications or require particular caution. Patients require monitoring for periwound skin maceration, bleeding, and dressing-related complications. Across the literature reviewed above, a consistent theme is that trial heterogeneity, variable blinding, and inconsistent adverse-event reporting limit the strength of conclusions that can be drawn, even where pooled point estimates favor NPWT.
Conclusion
Randomized trial and meta-analytic evidence accumulated over the past decade supports negative pressure wound therapy as an effective adjunct for selected diabetic foot wounds, particularly postoperative and post-debridement wounds. Higher-quality pooled analyses report faster granulation tissue formation, greater wound size reduction, and in some analyses a reduced amputation rate, generally without increased adverse events. At the same time, guideline bodies such as the IWGDF frame their support as conditional, and certainty of evidence across this literature remains only low to moderate due to heterogeneity, small trial sizes, and inconsistent reporting. Careful patient selection, vascular assessment, and proper wound bed preparation remain central to whatever outcomes NPWT can achieve.
References
Liu Z, Dumville JC, Hinchliffe RJ, Cullum N, Game F, Stubbs N, Sweeting M, Peinemann F. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2018;10:CD010318.
Chen P, et al. (International Working Group on the Diabetic Foot). Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3644.
Carmona-Torres JM, et al. Comparative Efficacy of Negative Pressure Wound Therapy and Conventional Treatments in the Management of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025;14(22):8051.
Du Y, Zhai T, Sheng Z, Xie W, Jia Z, Wen T, Zhao X, Tong X. Efficacy and Safety of Negative Pressure Wound Therapy in Diabetic Foot Ulcers: A Cross-Sectional Analysis of Overlapping Meta-Analyses. Diabetes, Metabolic Syndrome and Obesity. 2025;18:4099–4112.
Comments
